Leadership Overview
Piramal Pharma Solutions has 4 executives leading key functions including strategy, operations, technology, and global manufacturing.
Driven by a commitment to innovation, Piramal Pharma Solutions provides comprehensive end-to-end development and manufacturing solutions across the drug life cycle, solidifying its position as a trusted partner for innovator and generic companies worldwide.
Driven by a commitment to innovation, Piramal Pharma Solutions provides comprehensive end-to-end development and manufacturing solutions across the drug life cycle, solidifying its position as a trusted partner for innovator and generic companies worldwide.
Leadership Roles at Piramal Pharma Solutions
Bhargava Chari - Chief Executive Officer
Bhargava Chari, the Chief Executive Officer at Piramal Pharma Solutions, directs the overarching strategy and global operations of the Contract Development and Manufacturing Organization (CDMO). Chari's leadership ensures the seamless integration of services across the company's North American, European, and Asian facilities, driving the delivery of end-to-end solutions for drug discovery, development, and commercial supply. This executive guides the organization's expansion into specialized areas like highly potent APIs, antibody-drug conjugations, and sterile fill/finish, leveraging Piramal Pharma Limited's investments to enhance biologics capabilities. By fostering a culture of innovation and operational excellence, Bhargava Chari positions Piramal Pharma Solutions as a preferred partner for innovator and generic companies seeking reliable manufacturing and development expertise worldwide. The focus remains on expanding market reach and enhancing service offerings to meet evolving global pharmaceutical demands.
Sourabh Lodhi - Co-Chief Executive Officer
Sourabh Lodhi, the Co-Chief Executive Officer at Piramal Pharma Solutions, collaborates with the Chief Executive Officer to shape and execute the company's strategic vision. Lodhi's responsibilities encompass driving growth initiatives and ensuring operational efficiency across the global network of facilities. This leadership role involves overseeing the integration of Piramal Pharma Limited's investments, particularly in Yapan Bio Private Limited, to bolster capabilities in biologics, vaccines, gene therapies, and monoclonal antibodies. Sourabh Lodhi champions the expansion of specialized services, including the development and manufacturing of highly potent APIs and potent solid oral drug products. By focusing on customer-centric solutions and maintaining a high standard of quality, Lodhi ensures Piramal Pharma Solutions remains a trusted provider for both innovator and generic pharmaceutical companies globally. The objective is to enhance the company's competitive edge through strategic partnerships and service diversification.
Herve Berdou - Chief Operating Officer
Herve Berdou, the Chief Operating Officer at Piramal Pharma Solutions, directs the operational execution and global supply chain management for the Contract Development and Manufacturing Organization (CDMO). Berdou's leadership ensures the efficient functioning of facilities across North America, Europe, and Asia, facilitating the end-to-end delivery of pharmaceutical development and manufacturing services. This executive oversees the seamless production of clinical trial supplies, commercial APIs, and finished dosage forms, while also managing specialized manufacturing processes for highly potent compounds and antibody-drug conjugations. Herve Berdou plays a critical role in optimizing manufacturing processes for biologics, including vaccines and monoclonal antibodies, supporting Piramal Pharma Limited's strategic growth objectives. By maintaining stringent quality standards and driving operational excellence, Berdou reinforces Piramal Pharma Solutions' reputation as a reliable and experienced service provider for global pharmaceutical clients.
Rubina Malik - Chief Technology Officer
Rubina Malik, the Chief Technology Officer at Piramal Pharma Solutions, architects the technological roadmap and drives innovation across the company's global development and manufacturing operations. Malik's purview includes overseeing the implementation of advanced technologies for drug discovery, process development, and the commercial supply of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. This executive champions the integration of cutting-edge solutions for specialized services such as antibody-drug conjugations, sterile fill/finish, and peptide products. Rubina Malik also spearheads the technological advancements supporting the development and manufacturing of biologics, including vaccines and gene therapies, aligning with Piramal Pharma Limited's strategic investments. By ensuring robust technological infrastructure and fostering a culture of continuous improvement, Malik enhances Piramal Pharma Solutions' capacity to deliver complex pharmaceutical solutions and maintain its status as a partner of choice worldwide.
Explore Leadership Teams in Manufacturing
Eisai is a global pharmaceutical manufacturing company founded in 1941. The company develops and produces medicines while focusing on a human health care approach that extends beyond traditional pharmaceutical services. Eisai operates across multiple regions including North America, Europe, Asia Pacific, and the Middle East, with a strong presence in countries such as the United States, Japan, China, and the United Kingdom. The company maintains a significant focus on research and development in the pharmaceutical sector, with particular emphasis on patient-centered healthcare solutions. Eisai's business model encompasses both business-to-business and business-to-consumer operations, reflecting its comprehensive approach to healthcare delivery and pharmaceutical development.
Company Leadership
SG
YF
USV Private Limited is an Indian multinational pharmaceutical and biotechnology company headquartered in Mumbai, India. USV Limited was established in 1961.
Company Leadership SB
AM
SY
Unither Pharmaceuticals is a global contract development and manufacturing organization (CDMO) specializing in the production of single-dose liquid pharmaceuticals and sterile unit-dose formats for the pharmaceutical and consumer healthcare industries. The company is recognized as a world leader in blow-fill-seal technology, an advanced aseptic manufacturing process that forms, fills, and seals plastic containers in a continuous automated operation, ensuring high levels of sterility and product integrity. Unither's expertise encompasses the development and manufacturing of various liquid dosage forms including oral solutions, suspensions, nasal sprays, eye drops, and other sterile and non-sterile pharmaceutical products delivered in innovative single-dose formats. The company serves a diverse client base of pharmaceutical companies, biotechnology firms, and consumer health brands, providing comprehensive services from formulation development and clinical trial manufacturing to commercial-scale production and packaging. With manufacturing facilities strategically located across multiple continents including Europe and North America, Unither maintains strict quality standards and regulatory compliance with international pharmaceutical guidelines including FDA and EMA requirements. The company emphasizes innovation in drug delivery systems, patient convenience, and sustainability while helping clients bring their pharmaceutical products to market efficiently through its specialized manufacturing capabilities and technical expertise in unit-dose liquid formulations.
Company Leadership
ML
JK
GG
Founded in 1850 and headquartered in Johannesburg, South Africa, Aspen Pharmacare Holdings Limited is a global specialty and branded pharmaceutical company headquartered in Durban, South Africa. Operating across Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia, Aspen focuses on sterile injectables (including anaesthetics, anticoagulants, antithrombotics, analgesics, and hormone replacement therapies), over-the-counter medicines, and prescription products for conditions such as hypothyroidism, autoimmune disease, pain, gout, and inflammatory disorders. The company also manufactures active pharmaceutical ingredients and finished dose forms, including steriles, oral solids, liquids, semi-solids, biologicals, and heparins, supplying both its own brands and third-party customers worldwide.
Company Leadership
TS
RM
Frequently Asked Questions Regarding Piramal Pharma Solutions Top Executives and Leadership Team
